110 related articles for article (PubMed ID: 23813439)
41. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
42. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
43. Core binding factor β (CBFβ) is retained in the midbody during cytokinesis.
Lopez-Camacho C; van Wijnen AJ; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2014 Oct; 229(10):1466-74. PubMed ID: 24648201
[TBL] [Abstract][Full Text] [Related]
44. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages.
Tachibana M; Tenno M; Tezuka C; Sugiyama M; Yoshida H; Taniuchi I
J Immunol; 2011 Feb; 186(3):1450-7. PubMed ID: 21178013
[TBL] [Abstract][Full Text] [Related]
45. Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex.
Barton JL; Bunka DH; Knowling SE; Lefevre P; Warren AJ; Bonifer C; Stockley PG
Nucleic Acids Res; 2009 Nov; 37(20):6818-30. PubMed ID: 19740763
[TBL] [Abstract][Full Text] [Related]
46. Extrinsic and intrinsic signals converge on the Runx1/CBFβ transcription factor for nonpeptidergic nociceptor maturation.
Huang S; O'Donovan KJ; Turner EE; Zhong J; Ginty DD
Elife; 2015 Sep; 4():e10874. PubMed ID: 26418744
[TBL] [Abstract][Full Text] [Related]
47. Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer.
Bowers SR; Calero-Nieto FJ; Valeaux S; Fernandez-Fuentes N; Cockerill PN
Nucleic Acids Res; 2010 Oct; 38(18):6124-34. PubMed ID: 20483917
[TBL] [Abstract][Full Text] [Related]
48. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.
Talebian L; Li Z; Guo Y; Gaudet J; Speck ME; Sugiyama D; Kaur P; Pear WS; Maillard I; Speck NA
Blood; 2007 Jan; 109(1):11-21. PubMed ID: 16940420
[TBL] [Abstract][Full Text] [Related]
49. Biological implications of filamin A-bound PEBP2beta/CBFbeta retention in the cytoplasm.
Watanabe T; Yoshida N; Satake M
Crit Rev Eukaryot Gene Expr; 2005; 15(3):197-206. PubMed ID: 16390316
[TBL] [Abstract][Full Text] [Related]
50. The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context.
Khan AS; Campbell KJ; Cameron ER; Blyth K
Cells; 2023 Feb; 12(4):. PubMed ID: 36831308
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional activation of CBFβ by CDK11
Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
Cell Commun Signal; 2019 Oct; 17(1):125. PubMed ID: 31610798
[TBL] [Abstract][Full Text] [Related]
52. A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells.
Ran R; Harrison H; Syamimi Ariffin N; Ayub R; Pegg HJ; Deng W; Mastro A; Ottewell PD; Mason SM; Blyth K; Holen I; Shore P
Oncogene; 2020 Mar; 39(12):2624-2637. PubMed ID: 32005976
[TBL] [Abstract][Full Text] [Related]
53. CBFbeta is a facultative Runx partner in the sea urchin embryo.
Robertson AJ; Dickey-Sims C; Ransick A; Rupp DE; McCarthy JJ; Coffman JA
BMC Biol; 2006 Feb; 4():4. PubMed ID: 16469111
[TBL] [Abstract][Full Text] [Related]
54. CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner.
Wang C; Shi Z; Zhang Y; Li M; Zhu J; Huang Z; Zhang J; Chen J
Cell Death Differ; 2021 Nov; 28(11):3176-3192. PubMed ID: 34050318
[TBL] [Abstract][Full Text] [Related]
55. The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.
Riggio AI; Blyth K
FEBS J; 2017 Aug; 284(15):2345-2362. PubMed ID: 28304148
[TBL] [Abstract][Full Text] [Related]
56. The evolutionary origin of the Runx/CBFbeta transcription factors--studies of the most basal metazoans.
Sullivan JC; Sher D; Eisenstein M; Shigesada K; Reitzel AM; Marlow H; Levanon D; Groner Y; Finnerty JR; Gat U
BMC Evol Biol; 2008 Aug; 8():228. PubMed ID: 18681949
[TBL] [Abstract][Full Text] [Related]
57. Lactosylceramide contributes to mitochondrial dysfunction in diabetes.
Novgorodov SA; Riley CL; Yu J; Keffler JA; Clarke CJ; Van Laer AO; Baicu CF; Zile MR; Gudz TI
J Lipid Res; 2016 Apr; 57(4):546-62. PubMed ID: 26900161
[TBL] [Abstract][Full Text] [Related]
58. CBFβ and the leukemogenic fusion protein CBFβ-SMMHC associate with mitotic chromosomes to epigenetically regulate ribosomal genes.
Lopez-Camacho C; van Wijnen AJ; Lian JB; Stein JL; Stein GS
J Cell Biochem; 2014 Dec; 115(12):2155-64. PubMed ID: 25079347
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking.
Rose JT; Moskovitz E; Boyd JR; Gordon JA; Bouffard NA; Fritz AJ; Illendula A; Bushweller JH; Lian JB; Stein JL; Zaidi SK; Stein GS
Oncotarget; 2020 Jun; 11(26):2512-2530. PubMed ID: 32655837
[TBL] [Abstract][Full Text] [Related]
60. Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification.
Guo Y; Maillard I; Chakraborti S; Rothenberg EV; Speck NA
Blood; 2008 Aug; 112(3):480-92. PubMed ID: 18390836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
